數位PCR市場規模及預測(2021-2031年),全球及區域佔有率、趨勢、成長機會分析報告:按產品、應用及最終用戶分類
市場調查報告書
商品編碼
1938279

數位PCR市場規模及預測(2021-2031年),全球及區域佔有率、趨勢、成長機會分析報告:按產品、應用及最終用戶分類

dPCR Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, End user

出版日期: | 出版商: The Insight Partners | 英文 269 Pages | 訂單完成後即時交付

價格
根據我們最新的研究報告《2031年數位PCR市場預測—全球分析—按產品、應用和最終用戶分類》,預計該市場將從2024年的75.2億美元成長到2031年的143.4億美元,2025年至2031年的複合年成長率為9.9% 。成長要素包括對高靈敏度和高精度核酸檢測的需求、在臨床診斷和個人化醫療領域不斷擴大的應用,以及數位PCR技術和自動化的進步。

數位PCR (dPCR) 是一種先進的分子生物學技術,用於精確定量DNA或RNA分子。與傳統PCR批量測量擴增程度不同,dPCR將樣本分成數千個微反應,並對每個等分樣本進行單獨分析。透過計數陽性反應的數量,無需標準曲線即可實現絕對定量,從而能夠高靈敏度地檢測低豐度或稀有基因標靶。 dPCR廣泛應用於臨床診斷、感染疾病檢測、腫瘤學、法醫學和調查等領域,即使在分析傳統PCR難以處理的劣化或複雜樣本時,也能提供卓越的準確性和可重複性。

北美數位PCR(dPCR)市場分為美國、加拿大和墨西哥三個部分。美國數位PCR市場的成長主要受各醫療領域對精準、靈敏診斷工具日益成長的需求所驅動。據美國疾病管制與預防中心(CDC)稱,包括新冠肺炎(COVID-19)在內的感染疾病的傳播持續推動著對先進檢測方法的需求,診斷檢測量預計將從2022年的2億次激增至2023年的2.5億次。 CDC預測,對高品質診斷(尤其是病毒RNA和基因突變檢測)的需求將持續成長,而dPCR技術因其高特異性和高靈敏度而備受關注。此外,新產品的開發也促進了市場成長。例如,2023年,美國食品藥物管理局(FDA)核准了幾種用於腫瘤學的新型dPCR檢測方法,使液態生物檢體技術能夠實現癌症的早期檢測。此外,根據美國國家癌症研究所的研究,預計到 2024 年將新增約 190 萬例癌症病例,這將推動腫瘤學領域對精確分子診斷的需求。

拓展至微生物學和公共衛生監測領域,將帶來未來的市場機會。

將數位PCR (dPCR) 技術拓展至微生物學和公共衛生監測領域,為擴大其在感染疾病監測和微生物診斷中的應用提供了廣闊前景。 2024年6月,凱傑公司宣佈在其QIAcuity平台上推出35種經濕實驗室驗證的新型微生物DNA檢測方法,這些方法可檢測登革病毒(1-4型)、猴痘病毒(I系和II系)、瘧疾原蟲以及抗生素抗藥性基因等病原體。這些檢測方法提高了病原體定量分析的準確性和靈敏度,使公共衛生實驗室能夠監測疫情爆發、追蹤抗藥性並快速反應。透過凱傑公司的GeneGlobe入口網站,這些檢測方法得以廣泛應用,並使用便利。 dPCR無需標準曲線即可提供絕對定量結果,從而降低了變異性,並提高了實驗室間的可比性,使其在合作監測計畫中至關重要。根據《應用實驗室醫學雜誌》的一篇綜述,數位PCR的臨床應用包括微生物學和感染疾病診斷,不斷擴充的檢驗微生物檢測方法組合正在降低其在臨床和公共衛生領域的應用門檻。隨著各國政府和國際組織將基因組流行病學列為優先事項,這些進展為數位PCR成為全球衛生監測和疫情應變的重要工具創造了絕佳機會。

目錄

第1章 引言

第2章執行摘要

  • 主要發現

第3章調查方法

  • 調查範圍
  • 二次調查
  • 初步調查

第4章 dPCR市場概況

  • PEST分析
    • 世界PEST分析

第5章 dPCR市場-主要產業趨勢

  • 市場促進因素
    • 對高靈敏度和高精度核酸檢測的需求日益成長
    • 在臨床診斷和個人化醫療領域不斷拓展的應用
    • 數位PCR技術和自動化方面的進展
  • 市場限制
    • 設備和耗材高成本
    • 缺乏標準化和監管指導
    • 技術複雜性和對專業知識的需求
  • 市場機遇
    • 細胞和基因治療品管領域的發展
    • 拓展至微生物學和公共衛生監測領域
    • 非侵入性產前檢測(NIPT)和生殖遺傳學
  • 未來趨勢
    • 數位PCR系統的微型化與便攜性
    • 液態生物檢體在癌症診斷的應用日益廣泛
    • 自動化和生物資訊學整合以增強工作流程
  • 影響分析

第6章 dPCR市場-全球市場分析

  • 2021-2031年數位PCR市場收入

7. 全球數位PCR市場-收入與預測-按產品分類

  • dPCR市場收入佔有率(依產品分類,2021年及2031年)(%)
  • 試劑和耗材
  • 裝置
  • 軟體和服務

8. 全球數位PCR市場-收入及至2031年預測-按應用領域分類

  • 按應用領域分類的dPCR市場收入佔有率(2021年和2031年)(%)
  • 研究用途
  • 臨床應用
  • 法醫學應用

9. 全球數位PCR市場-收入及至2031年預測-依最終用戶分類

  • 按最終用戶分類的dPCR市場收入佔有率,2021年和2031年(%)
  • 醫院和診斷中心
  • 製藥和生物技術公司
  • 研究和學術機構
  • 法醫學研究所
  • 臨床研究所

第10章 dPCR市場—區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區
  • 南美洲及中南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲和中美洲

第11章:dPCR市場的產業現狀

  • dPCR市場成長策略
  • 內部成長策略
  • 內部成長策略

第12章:公司簡介

  • Sysmex Inostics Inc
  • Thermo Fisher Scientific Inc
  • Takara Bio Inc
  • Qiagen NV
  • Stilla Technologies
  • bioMerieux SALtd
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc
  • Standard BioTools Inc

第13章附錄

Product Code: TIPRE00042218

According to our new research study on "dPCR Market Forecast to 2031 -Global Analysis - by Product, Application, and End User," the market is anticipated to grow from US$7.52 billion in 2024 to US$14.34 billion by 2031; the market is expected to register a CAGR of 9.9% from 2025 to 2031. The dPCR Market growth is attributed to the demand for highly sensitive and accurate nucleic acid detection, expanding applications in clinical diagnostics and personalized medicine, and rising advancements in dPCR technology and automation.

Digital PCR (dPCR) is an advanced molecular biology technique used to precisely quantify DNA or RNA molecules. Unlike traditional PCR, which measures amplification in bulk, dPCR partitions a sample into thousands of tiny reactions, with each partition analyzed individually. By counting the number of positive reactions, it provides absolute quantification without the need for standard curves, making it highly sensitive for detecting low-abundance or rare genetic targets. dPCR is widely used in clinical diagnostics, infectious disease detection, oncology, forensics, and research, offering superior precision, reproducibility, and the ability to analyze degraded or complex samples that traditional PCR struggles with.

The dPCR Market in North America is segmented into the US, Canada, and Mexico. The growth of the US digital PCR Market is largely attributed to the increasing demand for precise and sensitive diagnostic tools in various medical fields. According to the Centers for Disease Control and Prevention (CDC), the prevalence of infectious diseases, including COVID-19, continues to drive the need for advanced testing methods, with diagnostic test volumes soaring from 200 million in 2022 to an estimated 250 million in 2023. As the CDC projects an enduring need for high-quality diagnostics, particularly in the detection of viral RNA and genetic mutations, dPCR technology has gained prominence for its enhanced specificity and sensitivity. Additionally, new product developments have contributed to market growth; for instance, in 2023, the US Food and Drug Administration (FDA) approved several novel dPCR assays for oncology, enabling earlier detection of cancers through liquid biopsy techniques. Furthermore, a study by the National Cancer Institute reported that, by 2024, ~1.9 million new cancer cases are expected to be diagnosed, fueling the demand for accurate molecular diagnostics in oncology.

Expansion into Microbial and Public Health Surveillance to Provide Market Opportunities in Future

Expansion into microbial and public health surveillance is a promising opportunity that lies in the expansion of dPCR into infectious disease surveillance and microbial diagnostics. In June 2024, QIAGEN launched 35 new wet-lab-tested microbial DNA detection assays on its QIAcuity platform, targeting pathogens including Dengue virus (serotypes 1-4), Monkeypox (clades I & II), malaria parasites, and antibiotic-resistance genes. These assays enhance the precision and sensitivity of pathogen quantification, enabling public-health labs to monitor outbreaks, track resistance, and respond more swiftly. These assays are available via QIAGEN's GeneGlobe portal, promoting broad access and ease of use. The ability of dPCR to provide absolute quantification without standard curves reduces variability and improves comparability between labs, which is crucial for coordinated surveillance programs. According to a review in The Journal of Applied Laboratory Medicine, clinical applications of dPCR include microbiology and infectious disease diagnostics, and the increasing portfolio of validated microbial assays lowers the barrier to clinical and public health adoption. As governments and international agencies increasingly prioritize genomic epidemiology, these developments create a strong opportunity for dPCR to become an integral tool in global health surveillance and outbreak response.

World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), American Chemical Society Publications, The U.S. Centers for Medicare & Medicaid Services (CMS), US Department of Health & Human Services, Public Health Agency of Canada (PHAC), French National Institute of Health and Medical Research (INSERM), Italian National Institute of Health (ISS), The Korean Journal of Internal Medicine, the Saudi Press Agency (SPA), UAE Ministry of Health and Prevention (MOHAP) are among the primary and secondary sources referred to while preparing the dPCR Market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. dPCR Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. dPCR Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Demand for Highly Sensitive and Accurate Nucleic Acid Detection
    • 5.1.2 Expanding Applications in Clinical Diagnostics and Personalized Medicine
    • 5.1.3 Rising Advancements in dPCR Technology and Automation
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Instrumentation and Consumables
    • 5.2.2 Lack of Standardization and Regulatory Guidance
    • 5.2.3 Technical Complexity and Need for Specialized Expertise
  • 5.3 Market Opportunities
    • 5.3.1 Growth in Cell & Gene Therapy Quality Control
    • 5.3.2 Expansion into Microbial and Public Health Surveillance
    • 5.3.3 Noninvasive Prenatal Testing (NIPT) and Reproductive Genetics
  • 5.4 Future Trends
    • 5.4.1 Miniaturization and Portability of dPCR Systems
    • 5.4.2 Increased Adoption in Liquid Biopsy for Cancer Diagnostics
    • 5.4.3 Integration with Automation and Bioinformatics for Enhanced Workflow
  • 5.5 Impact Analysis:

6. dPCR Market - Global Market Analysis

  • 6.1 dPCR Market Revenue (US$ Mn), 2021 - 2031

7. Global dPCR Market - Revenue and Forecast to 2031 - by Product

  • 7.1 Overview
  • 7.2 dPCR Market Revenue Share, by Product, 2021 & 2031(%)
  • 7.3 Reagents & Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents & Consumables: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Software & Services
    • 7.5.1 Overview
    • 7.5.2 Software & Services: dPCR Market - Revenue and Forecast to 2031 (US$ Million)

8. Global dPCR Market - Revenue and Forecast to 2031 - by Application

  • 8.1 Overview
  • 8.2 dPCR Market Revenue Share, by Application, 2021 & 2031(%)
  • 8.3 Research Application
    • 8.3.1 Overview
    • 8.3.2 Research Application: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Clinical Application
    • 8.4.1 Overview
    • 8.4.2 Clinical Application: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
      • 8.4.2.1 dPCR Market, by Clinical Application, 2021-2031 (US$ Million)
  • 8.5 Forensic Application
    • 8.5.1 Overview
    • 8.5.2 Forensic Application: dPCR Market - Revenue and Forecast to 2031 (US$ Million)

9. Global dPCR Market - Revenue and Forecast to 2031 - by End-User

  • 9.1 Overview
  • 9.2 dPCR Market Revenue Share, by End-User, 2021 & 2031(%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Pharmaceutical and Biotechnology Companies
    • 9.4.1 Overview
    • 9.4.2 Pharmaceutical and Biotechnology Companies: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Research Laboratories and Academic Institutes
    • 9.5.1 Overview
    • 9.5.2 Research Laboratories and Academic Institutes: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Forensic Laboratories
    • 9.6.1 Overview
    • 9.6.2 Forensic Laboratories: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.7 Clinical Research Organizations
    • 9.7.1 Overview
    • 9.7.2 Clinical Research Organizations: dPCR Market - Revenue and Forecast to 2031 (US$ Million)

10. dPCR Market - Geographical Analysis

  • 10.1 North America dPCR Market, Revenue and Forecast To 2031
    • 10.1.1 Overview
    • 10.1.2 North America dPCR Market Revenue and Forecast to 2031 (US$ Mn)
    • 10.1.3 North America: dPCR Market, by Product, 2021-2031 (US$ Million)
    • 10.1.4 North America: dPCR Market, by Application, 2021-2031 (US$ Million)
      • 10.1.4.1 North America: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
    • 10.1.5 North America: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.1.5.1 North America dPCR Market, by Country
      • 10.1.5.2 US
        • 10.1.5.2.1 US dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.1.5.2.2 US: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.1.5.2.3 US: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.1.5.2.4.1 US: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.1.5.2.5 US: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.1.5.3 Canada
        • 10.1.5.3.1 Canada dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.1.5.3.2 Canada: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.1.5.3.3 Canada: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.1.5.3.4.1 Canada: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.1.5.3.5 Canada: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.1.5.4 Mexico
        • 10.1.5.4.1 Mexico dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.1.5.4.2 Mexico: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.1.5.4.3 Mexico: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.1.5.4.3.1 Mexico: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.1.5.4.4 Mexico: dPCR Market, by End-User, 2021-2031 (US$ Million)
  • 10.2 Europe dPCR Market, Revenue and Forecast to 2031
    • 10.2.1 Overview
    • 10.2.2 Europe dPCR Market Revenue and Forecast to 2031 (US$ Mn)
    • 10.2.3 Europe: dPCR Market, by Product, 2021-2031 (US$ Million)
    • 10.2.4 Europe: dPCR Market, by Application, 2021-2031 (US$ Million)
      • 10.2.4.1 Europe: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
    • 10.2.5 Europe: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.2.5.1 Europe dPCR Market, by Country
      • 10.2.5.2 UK
        • 10.2.5.2.1 UK dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.2.5.2.2 UK: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.2.5.2.3 UK: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.2.5.2.3.1 UK: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.2.5.2.4 UK: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.2.5.3 Germany
        • 10.2.5.3.1 Germany dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.2.5.3.2 Germany: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.2.5.3.3 Germany: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.2.5.3.3.1 Germany: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.2.5.3.4 Germany: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.2.5.4 France
        • 10.2.5.4.1 France dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.2.5.4.2 France: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.2.5.4.3 France: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.2.5.4.3.1 France: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.2.5.4.4 France: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.2.5.5 Italy
        • 10.2.5.5.1 Italy dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.2.5.5.2 Italy: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.2.5.5.3 Italy: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.2.5.5.3.1 Italy: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.2.5.5.4 Italy: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.2.5.6 Spain
        • 10.2.5.6.1 Spain dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.2.5.6.2 Spain: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.2.5.6.3 Spain: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.2.5.6.3.1 Spain: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.2.5.3.5 Spain: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.2.5.7 Rest of Europe
        • 10.2.5.7.1 Rest of Europe dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.2.5.7.2 Rest of Europe: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.2.5.7.3 Rest of Europe: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.2.5.7.3.1 Rest of Europe: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.2.5.7.4 Rest of Europe: dPCR Market, by End-User, 2021-2031 (US$ Million)
  • 10.3 Asia Pacific dPCR Market, Revenue and Forecast to 2031
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific dPCR Market Revenue and Forecast to 2031 (US$ Mn)
    • 10.3.3 Asia Pacific: dPCR Market, by Product, 2021-2031 (US$ Million)
    • 10.3.4 Asia Pacific: dPCR Market, by Application, 2021-2031 (US$ Million)
      • 10.3.4.1 Asia Pacific: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
    • 10.3.5 Asia Pacific: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.1 Asia Pacific dPCR Market, by Country
      • 10.3.5.2 China
        • 10.3.5.2.1 China dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.2.2 China: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.2.3 China: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.2.3.1 China: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.2.4 China: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.3 Japan
        • 10.3.5.3.1 Japan dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.3.2 Japan: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.3.3 Japan: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.3.3.1 Japan: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.3.4 Japan: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.4 India
        • 10.3.5.4.1 India dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.4.2 India: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.4.3 India: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.4.3.1 India: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.4.4 India: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.5 Australia
        • 10.3.5.5.1 Australia dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.5.2 Australia: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.5.3 Australia: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.5.3.1 Australia: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.5.4 Australia: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.6 South Korea
        • 10.3.5.6.1 South Korea dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.6.2 South Korea: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.6.3 South Korea: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.6.3.1 South Korea: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.6.4 South Korea: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.7 Rest of Asia Pacific
        • 10.3.5.7.1 Rest of Asia Pacific dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.7.2 Rest of Asia Pacific: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.7.3 Rest of Asia Pacific: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.7.3.1 Rest of Asia Pacific: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.7.4 Rest of Asia Pacific: dPCR Market, by End-User, 2021-2031 (US$ Million)
  • 10.4 Middle East & Africa dPCR Market, Revenue and Forecast to 2031
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa dPCR Market Revenue and Forecast to 2031 (US$ Mn)
    • 10.4.3 Middle East & Africa: dPCR Market, by Product, 2021-2031 (US$ Million)
    • 10.4.4 Middle East & Africa: dPCR Market, by Application, 2021-2031 (US$ Million)
      • 10.4.4.1 Middle East & Africa: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
    • 10.4.5 Middle East & Africa: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.1 Middle East & Africa dPCR Market, by Country
      • 10.3.5.2 Saudi Arabia
        • 10.3.5.2.1 Saudi Arabia dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.2.2 Saudi Arabia: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.2.3 Saudi Arabia: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.2.3.1 Saudi Arabia: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.2.4 Saudi Arabia: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.3 UAE
        • 10.3.5.3.1 UAE dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.3.2 UAE: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.3.3 UAE: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.3.3.1 UAE: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.3.5 UAE: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.4 South Africa
        • 10.3.5.4.1 South Africa dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.4.2 South Africa: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.4.3 South Africa: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.4.3.1 South Africa: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.4.4 South Africa: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.5 Rest of Middle East & Africa
        • 10.3.5.5.1 Rest of Middle East & Africa dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.5.2 Rest of Middle East & Africa: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.5.3 Rest of Middle East & Africa: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.5.3.1 Rest of Middle East & Africa: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.5.4 Rest of Middle East & Africa: dPCR Market, by End-User, 2021-2031 (US$ Million)
  • 10.5 South & Central America dPCR Market, Revenue and Forecast to 2031
    • 10.5.1 Overview
    • 10.5.2 South & Central America dPCR Market Revenue and Forecast to 2031 (US$ Mn)
    • 10.5.3 South & Central America: dPCR Market, by Product, 2021-2031 (US$ Million)
    • 10.5.4 South & Central America: dPCR Market, by Application, 2021-2031 (US$ Million)
      • 10.5.4.1 South & Central America: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
    • 10.5.5 South & Central America: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.5.5.1 South & Central America dPCR Market, by Country
      • 10.5.5.2 Brazil
        • 10.5.5.2.1 Brazil dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.5.5.2.2 Brazil: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.5.5.2.3 Brazil: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.5.5.2.3.1 Brazil: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.5.5.2.4 Brazil: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.5.5.3 Argentina
        • 10.5.5.3.1 Argentina dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.5.5.3.2 Argentina: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.5.5.3.3 Argentina: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.5.5.3.3.1 Argentina: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.5.5.3.4 Argentina: dPCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.5.5.4 Rest of South & Central America
        • 10.5.5.4.1 Rest of South & Central America dPCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.5.5.4.2 Rest of South & Central America: dPCR Market, by Product, 2021-2031 (US$ Million)
        • 10.5.5.4.3 Rest of South & Central America: dPCR Market, by Application, 2021-2031 (US$ Million)
          • 10.5.5.4.3.1 Rest of South & Central America: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.5.5.4.4 Rest of South & Central America: dPCR Market, by End-User, 2021-2031 (US$ Million)

11. dPCR Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in dPCR Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Sysmex Inostics Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Thermo Fisher Scientific Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Takara Bio Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Qiagen NV
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Stilla Technologies
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 bioMerieux SALtd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 F. Hoffmann-La Roche Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Bio-Rad Laboratories Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Agilent Technologies Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Standard BioTools Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 SWOT Analysis
    • 12.10.5 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. dPCR Market Segmentation
  • Table 2. dPCR Market, by Clinical Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. North America dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 4. North America dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 5. North America dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 6. North America dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 7. US dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 8. US dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 9. US dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 10. US dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 11. Canada dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 12. Canada dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 13. Canada dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 14. Canada dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 15. Mexico dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 16. Mexico dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 17. Mexico dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 18. Mexico dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 19. Europe dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 20. Europe dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 21. Europe dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 22. Europe dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 23. UK dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 24. UK dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 25. UK dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 26. UK dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 27. Germany dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 28. Germany dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 29. Germany dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 30. Germany dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 31. France dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 32. France dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 33. France dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 34. France dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 35. Italy dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 36. Italy dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 37. Italy dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 38. Italy dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 39. Spain dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 40. Spain dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 41. Spain dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 42. Spain dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 43. Rest of Europe dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 44. Rest of Europe dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 45. Rest of Europe dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 46. Rest of Europe dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 47. Asia Pacific dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 48. Asia Pacific dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 49. Asia Pacific dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 50. Asia Pacific dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 51. China dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 52. China dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 53. China dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 54. China dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 55. Japan dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 56. Japan dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 57. Japan dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 58. Japan dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 59. India dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 60. India dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 61. India dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 62. India dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 63. Australia dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 64. Australia dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 65. Australia dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 66. Australia dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 67. South Korea dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 68. South Korea dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 69. South Korea dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 70. South Korea dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 71. Rest of Asia Pacific dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 72. Rest of Asia Pacific dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 73. Rest of Asia Pacific dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 74. Rest of Asia Pacific dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 75. Middle East & Africa dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 76. Middle East & Africa dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 77. Middle East & Africa dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 78. Middle East & Africa dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 79. Saudi Arabia dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 80. Saudi Arabia dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 81. Saudi Arabia dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 82. Saudi Arabia dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 83. UAE dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 84. UAE dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 85. UAE dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 86. UAE dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 87. South Africa dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 88. South Africa dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 89. South Africa dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 90. South Africa dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 91. Rest of Middle East & Africa dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 92. Rest of Middle East & Africa dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 93. Rest of Middle East & Africa dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 94. Rest of Middle East & Africa dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 95. South & Central America dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 96. South & Central America dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 97. South & Central America dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 98. South & Central America dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 99. Brazil dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 91. Brazil dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 92. Brazil dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 93. Brazil dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 94. Argentina dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 95. Argentina dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 96. Argentina dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 97. Argentina dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 98. Rest of South & Central America dPCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 99. Rest of South & Central America dPCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 100. Rest of South & Central America dPCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 101. Rest of South & Central America dPCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 102. Recent Organic Growth Strategies in dPCR Market
  • Table 103. Recent Inorganic Growth Strategies in the dPCR Market
  • Table 104. Glossary of Terms, dPCR Market

List Of Figures

  • Figure 1. dPCR Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. dPCR Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. dPCR Market Revenue (US$ Mn), 2021 - 2031
  • Figure 6. dPCR Market Revenue, Geography (US$ Mn), 2021 - 2031
  • Figure 7. Quantitative PCR: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Digital PCR: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. dPCR Market Revenue Share, by Product, 2021 & 2031(%)
  • Figure 10. Reagents & Consumables: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Instruments: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Software & Services: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. dPCR Market Revenue Share, by Application, 2021 & 2031(%)
  • Figure 14. Research Application: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Clinical Application: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Forensic Application: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. dPCR Market Revenue Share, by End-User, 2021 & 2031(%)
  • Figure 18. Hospitals and Diagnostic Centers: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Pharmaceutical and Biotechnology Companies: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Research Laboratories and Academic Institutes: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Forensic Laboratories: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Clinical Research Organizations: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. North America: dPCR Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 24. North America dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 25. North America dPCR Market, By Key Countries, 2022 and 2031 (%)
  • Figure 26. US dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 27. Canada dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 28. Mexico dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 29. Europe dPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 30. Europe dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 31. Europe dPCR Market, By Key Countries, 2022 and 2031 (%)
  • Figure 32. UK dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 33. Germany dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 34. France dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 35. Italy dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 36. Spain dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 37. Rest of Europe dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 38. Asia Pacific dPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 39. Asia Pacific dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 40. Asia Pacific dPCR Market, By Key Countries, 2022 and 2031 (%)
  • Figure 41. China dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 42. Japan dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 43. India dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 44. Australia dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 45. South Korea dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 46. Rest of Asia Pacific dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 47. Middle East & Africa dPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 48. Middle East & Africa dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 49. Middle East & Africa dPCR Market, By Key Countries, 2022 and 2031 (%)
  • Figure 50. Saudi Arabia dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 51. UAE dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 52. South Africa dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 53. Rest of Middle East & Africa dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 54. South & Central America dPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 55. South & Central America dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 56. South & Central America dPCR Market, By Key Countries, 2022 and 2031 (%)
  • Figure 57. Brazil dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 58. Argentina dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 59. Rest of South & Central America dPCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 60. Growth Strategies in dPCR Market